September 20, 2018
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549-4561
Attn: Jeffrey Gabor
| Re: | Daré Bioscience, Inc. |
| Registration Statement on Form S-3 (File No. 333-227022) |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced registration statement to 4:00 p.m., Eastern Standard Time, on Friday, September 21, 2018, or as soon thereafter as practicable.
Please contact the undersigned with any questions or comments at (858) 926-7655. Thank you for your assistance with this matter.
| Very truly yours, |
| Daré Bioscience, Inc. |
| /s/ Lisa Walters-Hoffert |
| Lisa Walters-Hoffert |
| Chief Financial Officer |